High Interleukin-8 Levels Associated With Decreased Survival in Patients With Cirrhosis Following Transjugular Intrahepatic Portosystemic Shunt
Authors:
Open Access
- 28 February 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 829245
Abstract
Background: Serum cytokines—reflecting systemic inflammation has been associated with the risk of decompensation and mortality in patients with cirrhosis. However, the role of systemic inflammation in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt procedure remains unknown.Patients and Methods: Patients with cirrhosis who received transjugular intrahepatic portosystemic shunt between June 2015 and September 2017 were included. Portal and hepatic venous blood samples were obtained intraoperatively; serum cytokine levels (IL-10, IL-17A, IL-1RA, IL-8, and CXCL10) were measured in 105 patients. Associations with survival and other outcomes during long-term follow-up (median: 1,564 days) were assessed using logistic regression.Results: IL-17A and CXCL10 levels were higher in the portal than in the hepatic veins, whereas IL-1RA levels were higher in the hepatic than in the portal veins. However, IL-8 or IL-10 levels between hepatic and portal veins showed no differences. Multivariate analysis demonstrated that Child–Pugh scores (P = 0.017, HR: 1.484, 95% CI: 1.072–2.055) and IL-8 level in hepatic veins (P < 0.001, HR: 1.043, 95% CI: 1.019–1.068) were independent predictors for mortality during long-term follow-up, with an optimal cut-off of 5.87 pg/ml for IL-8 in hepatic veins. Patients with hepatic IL-8 levels < 5.87 pg/ml had significantly higher cumulative survival rates (98.4 vs. 72.9% at 1 year, 98.4 vs. 65.3% at 2 years, 96.7 vs. 60.3% at 3 years, 94.2 vs. 60.3% at 4 years; P < 0.0001).Conclusions: IL-8 levels in hepatic veins may reflect liver cirrhosis severity. Elevated IL-8 levels suggest shorter survival in patients receiving TIPS.Keywords
This publication has 30 references indexed in Scilit:
- Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in MiceGastroenterology, 2012
- High-sensitivity C-reactive protein levels predict survival and are related to haemodynamics in alcoholic cirrhosisEuropean Journal of Gastroenterology & Hepatology, 2012
- Influence of elevated liver fat on circulating adipocytokines and insulin resistance in obese Hispanic adolescentsPediatric Obesity, 2012
- Some inflammatory cytokine levels, iron metabolism and oxidan stress markers in subjects with nonalcoholic steatohepatitisClinical Biochemistry, 2011
- Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseasesLiver International, 2011
- A Potential Role of the CXC Chemokine GROα in Atherosclerosis and Plaque DestabilizationArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Poster Round 5.1: Inflammation and Host ResponseHelicobacter, 2007
- Plasma interleukin‐8 levels in patients with post‐hepatitic cirrhosis: Relationship to severity of liver disease, portal hypertension and hyperdynamic circulationJournal of Gastroenterology and Hepatology, 1996
- Tumor Necrosis Factor–α Regulates In Vivo Nitric Oxide Synthesis and Induces Liver Injury During EndotoxemiaHepatology, 1994
- Interleukin‐8, a chemotactic and inflammatory cytokineFEBS Letters, 1992